Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo sold 734 shares of the stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $101.91, for a total transaction of $74,801.94. Following the sale, the senior vice president now owns 28,095 shares of the company’s stock, valued at approximately $2,863,161.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of Varian Medical Systems, Inc. (NYSE VAR) traded up 0.46% during midday trading on Wednesday, reaching $102.48. 622,962 shares of the company were exchanged. The company’s 50-day moving average price is $96.81 and its 200 day moving average price is $86.88. Varian Medical Systems, Inc. has a 52-week low of $68.08 and a 52-week high of $103.79. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of 33.07 and a beta of 0.63.

Varian Medical Systems (NYSE:VAR) last posted its earnings results on Wednesday, April 26th. The medical equipment provider reported $0.89 EPS for the quarter, topping the consensus estimate of $0.88 by $0.01. Varian Medical Systems had a net margin of 9.39% and a return on equity of 24.82%. The firm had revenue of $655 million during the quarter, compared to analysts’ expectations of $639.26 million. During the same quarter in the prior year, the firm earned $1.09 EPS. Varian Medical Systems’s quarterly revenue was up 6.5% on a year-over-year basis. On average, equities analysts predict that Varian Medical Systems, Inc. will post $3.90 earnings per share for the current year.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

WARNING: “John W. Kuo Sells 734 Shares of Varian Medical Systems, Inc. (VAR) Stock” was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/06/14/john-w-kuo-sells-734-shares-of-varian-medical-systems-inc-var-stock.html.

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vident Investment Advisory LLC boosted its position in Varian Medical Systems by 42.5% in the fourth quarter. Vident Investment Advisory LLC now owns 14,681 shares of the medical equipment provider’s stock valued at $1,318,000 after buying an additional 4,381 shares during the period. Hussman Strategic Advisors Inc. boosted its position in Varian Medical Systems by 9.0% in the first quarter. Hussman Strategic Advisors Inc. now owns 10,900 shares of the medical equipment provider’s stock valued at $993,000 after buying an additional 900 shares during the period. Teachers Advisors LLC boosted its position in Varian Medical Systems by 3.9% in the fourth quarter. Teachers Advisors LLC now owns 107,778 shares of the medical equipment provider’s stock valued at $9,676,000 after buying an additional 4,000 shares during the period. SFE Investment Counsel boosted its position in Varian Medical Systems by 17.7% in the first quarter. SFE Investment Counsel now owns 45,447 shares of the medical equipment provider’s stock valued at $4,142,000 after buying an additional 6,829 shares during the period. Finally, Cadence Capital Management LLC boosted its position in Varian Medical Systems by 11.7% in the fourth quarter. Cadence Capital Management LLC now owns 2,400 shares of the medical equipment provider’s stock valued at $215,000 after buying an additional 252 shares during the period. Hedge funds and other institutional investors own 99.68% of the company’s stock.

Several equities research analysts have recently weighed in on VAR shares. Zacks Investment Research upgraded shares of Varian Medical Systems from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 6th. Off Wall Street started coverage on shares of Varian Medical Systems in a research note on Monday, April 24th. They set a “sell” rating for the company. Royal Bank Of Canada increased their target price on shares of Varian Medical Systems from $82.00 to $90.00 and gave the stock a “sector perform” rating in a research note on Thursday, April 27th. Barrington Research downgraded shares of Varian Medical Systems from an “outperform” rating to a “market perform” rating in a research note on Thursday, April 27th. Finally, TheStreet upgraded shares of Varian Medical Systems from a “c+” rating to a “b+” rating in a research note on Wednesday, April 26th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $93.54.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.